Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for United States Antimony (UAMY) over the last 17 years, with Q3 2025 value amounting to $35.1 million.

  • United States Antimony's Cash from Financing Activities rose 10966718.85% to $35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.6 million, marking a year-over-year increase of 1647948.16%. This contributed to the annual value of $4.1 million for FY2024, which is 48626.56% up from last year.
  • As of Q3 2025, United States Antimony's Cash from Financing Activities stood at $35.1 million, which was up 10966718.85% from $4.1 million recorded in Q2 2025.
  • United States Antimony's 5-year Cash from Financing Activities high stood at $35.1 million for Q3 2025, and its period low was -$1.4 million during Q2 2023.
  • Its 5-year average for Cash from Financing Activities is $3.6 million, with a median of -$17798.0 in 2024.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 1128215000.0% in 2022, then skyrocketed by 10966718.85% in 2025.
  • United States Antimony's Cash from Financing Activities (Quarter) stood at -$2.0 in 2021, then tumbled by 11282150.0% to -$225645.0 in 2022, then grew by 5.38% to -$213513.0 in 2023, then skyrocketed by 2071.39% to $4.2 million in 2024, then skyrocketed by 734.75% to $35.1 million in 2025.
  • Its Cash from Financing Activities was $35.1 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.2 million in Q1 2025.